Procaine clinical trials
Also written SP01A.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 1997
How each study uses Procaine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 19 Sept 1952 · RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN · NDA 008592 (FDA, Drugs@FDA; in a combination)
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- SP01A
- 3
Studies by the year they started
3 studies that test it; most in 1997 (1)
| Year | Studies |
|---|---|
| 1997 | 1 |
| 2005 | 1 |
| 2006 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Samaritan Pharmaceuticals, Inc (3)
Related medicines
As reviewed, each with the page that says it.
- One of Local anesthetics source
Studies
Open first, then newest update. How each study uses Procaine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV PatientsStatus unknownPhase 2Samaritan Pharmaceuticals, IncNCT00299897Written as SP01A
- A Dose Response and Safety Study of Procaine HCl in HIV-Infected PatientsCompletedPhase 1/2Samaritan Pharmaceuticals, IncNCT00299338Written as SP01A
- A Study of an Oral Entry Inhibitor, SP01A, in Treatment-Experienced HIV-Infected PatientsStatus unknownPhase 2Samaritan Pharmaceuticals, IncNCT00113412Written as SP01A
Given beside what is tested · 1 — Procaine is usual care or a partner of the new treatment
Codes
What other systems call Procaine · ClinicalTrials.gg INT008093
- MeSH (NLM) D011343ProcaineConfirmed NLM, Wikidata
- UNII (FDA) 4Z8Y51M438PROCAINEConfirmed FDA, NLM, Wikidata
- RxNorm 8701Confirmed FDA, Wikidata
- Wikidata Q423741procaineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61906ProcaineOne source FDA
- DrugBank DB00721One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D011343 | Procaine | Confirmed NLM, Wikidata |
| UNII (FDA) | 4Z8Y51M438 | PROCAINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 8701 | — | Confirmed FDA, Wikidata |
| Wikidata | Q423741 | procaine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61906 | Procaine | One source FDA |
| DrugBank | DB00721 | — | One source Wikidata |
Also registered as procaine hydrochloride (UNII 95URV01IDQ · RxNorm 106558).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.